Category: Workers Comp

523 posts found

FDA Approves Novel Non-Opioid Journavx for Moderate to Severe Pain

A first-in-class medication, Journavx targets pain-signaling pathways involving sodium channels.

The seventh annual survey report highlights the top challenges and priorities for 515 industry stakeholders.

Various states are proposing modifications to existing presumptions to expand coverage for first responders.

A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.

Pandemic driven increases to provider vacancies have increased reliance on nurse practitioners and physician assistants.

Recent data insights, state proposals, and updates on federal rulemaking procedures.

Victoza® (liraglutide) injections are a GLP-1 receptor agonist, a drug class experiencing shortages due to their high demand.

Health trends to consider in this growing portion of the workforce.

The guidelines provide recommendations on using AI to demonstrate drug safety and effectiveness, and recommendations for AI-enabled medical devices.

Among many changes, the state is replacing AWP with a new pricing model.

Medical use would be legalized, with legal protections for patients and physicians.

How a good customer service center can create an exceptionally positive experience for customers, claims teams, and injured workers.

These drugs treat opioid withdrawal and opioid-induced constipation, respectively.

Sleep deprivation and fatigue have far-reaching consequences in the workplace, from poor productivity to injury or death.

All workers will now have the right to file a claim for mental injuries, based upon extraordinary work-related stress incurred on the job.

Prev 1 2 3 4 5 … 31 32 33 34 35 Next